Armata Pharma shares jump on FDA breakthrough designation
Armata Pharmaceuticals’ shares rose in premarket after the FDA granted breakthrough therapy designation for a potential antibacterial treatment.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.